US HB6839 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 12 2020 - 25% progression, died in committee
Action: 2020-05-12 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 12 2020 - 25% progression, died in committee
Action: 2020-05-12 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires the Government Accountability Office (GAO) to report on diagnostic tests to diagnose COVID-19 (i.e., coronavirus disease 2019) or detect the virus that causes the disease. Specifically, the report must describe the response of, among others, laboratories, diagnostic test manufacturers, and government entities with respect to the development, regulatory evaluation, and deployment of diagnostic tests. The GAO must also assess standards, guidance, clinical processes, and intergovernmental coordination related to COVID-19 testing.
Title
To direct the Comptroller General of the United States to submit a report describing the response of certain entities to the COVID-19 pandemic with respect to the development, regulatory evaluation, and deployment of diagnostic tests.
Sponsors
Rep. Abigail Spanberger [D-VA] | Rep. Anthony Gonzalez [R-OH] |
History
Date | Chamber | Action |
---|---|---|
2020-05-12 | House | Referred to the House Committee on Energy and Commerce. |
2020-05-12 | House | Introduced in House |
Same As/Similar To
HB6800 (Related) 2020-07-23 - Committee on Small Business and Entrepreneurship. Hearings held.
Subjects
Blood and blood diseases
Cardiovascular and respiratory health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Government studies and investigations
Health
Health facilities and institutions
Infectious and parasitic diseases
Medical tests and diagnostic methods
State and local government operations
Cardiovascular and respiratory health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Government studies and investigations
Health
Health facilities and institutions
Infectious and parasitic diseases
Medical tests and diagnostic methods
State and local government operations
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/6839/all-info |
Text | https://www.congress.gov/116/bills/hr6839/BILLS-116hr6839ih.pdf |